The NPM1 wild-type OCI-AML2 and the NPM1-mutated OCI-AML3 cell lines carry DNMT3A mutations

Leukemia

Volumn 26, Issue 3, 2012, Pages 554-557

  Tiacci, E ^a   Spanhol Rosseto, A ^a   Martelli, M P ^a   Pasqualucci, L ^b   Quentmeier, H ^c   Grossmann, V ^d   Drexler, H G ^c   Falini, B ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b Columbia University ^*  (United States)

^c LEIBNIZ INSTITUTE DSMZ GERMAN COLLECTION OF MICROORGANISMS AND CELL CULTURES   (Germany)

^d MLL MUNICH LEUKEMIA LABORATORY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; NUCLEOPHOSMIN;

ACUTE GRANULOCYTIC LEUKEMIA; CELL STRAIN HL 60; CELL STRAIN U937; DNA METHYLATION; DNMT3A GENE; EPIGENETICS; GENE MUTATION; GENE SEQUENCE; GENOME; HUMAN; HUMAN CELL; IDH 1 GENE; IDH 2 GENE; KARYOTYPE; LETTER; LEUKEMIA CELL LINE; NPM1 ONCOGENE; NUCLEOTIDE SEQUENCE; ONCOGENE; PATHOGENESIS; PRIORITY JOURNAL; WILD TYPE;

BASE SEQUENCE; CELL LINE, TUMOR; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; EXONS; GENOTYPE; HUMANS; LEUKEMIA, MYELOID, ACUTE; MUTATION; NUCLEAR PROTEINS;

EID: 84858008504     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2011.238     Document Type: Letter

References (17)

1. Arber DA, Brunning RD, Le Beau MM, Falini B, Vardiman JW, Porwit A et al. Acute myeloid leukaemia with recurrent genetic abnormalities. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al. (eds). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. International Agency for Research on Cancer (IARC): Lyon, France, 2008.
2. Falini B, Mecucci C, Tiacci E, Alcalay M, Rosati R, Pasqualucci L et al. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N Engl J Med 2005; 352: 254-266. (Pubitemid 40110814)
3. Falini B, Martelli MP, Bolli N, Sportoletti P, Liso A, Tiacci E et al. Acute myeloid leukemia with mutated nucleophosmin (NPM1): is it a distinct entity? Blood 2011; 117: 1109-1120.
4. Mardis ER, Ding L, Dooling DJ, Larson DE, McLellan MD, Chen K et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. N Engl J Med 2009; 361: 1058-1066.
5. Ley TJ, Ding L, Walter MJ, McLellan MD, Lamprecht T, Larson DE et al. DNMT3A mutations in acute myeloid leukemia. N Engl J Med 2010; 363: 2424-2433.
6. Yan XJ, Xu J, Gu ZH, Pan CM, Lu G, Shen Y et al. Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia. Nat Genet 2011; 43: 309-315.
7. Shannon K, Armstrong SA. Genetics, epigenetics, and leukemia. N Engl J Med 2011; 363: 2460-2461.
8. FigueroaME, Lugthart S, Li Y, Erpelinck-Verschueren C, Deng X, Christos PJ et al. DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia. Cancer Cell 2010; 17: 13-27.
9. Shah MY, Licht JD. DNMT3A mutations in acute myeloid leukemia. Nat Genet 2011; 43: 289-290.
10. Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 2009; 4: 1073-1081.
11. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P et al. A method and server for predicting damaging missense mutations. Nat Methods (2010); 7: 248-249.
12. Wang C, Curtis JE, Minden MD, McCulloch EA. Expression of a retinoic acid receptor gene in myeloid leukemia cells. Leukemia 1989; 3: 264-269. (Pubitemid 19092758)
13. Walter MJ, Ding L, Shen D, Shao J, Grillot M, McLellan M et al. Recurrent DNMT3A mutations in patients with myelodysplastic syndromes. Leukemia 2011; 25: 1153-1158.
14. Quentmeier H, Martelli MP, Dirks WG, Bolli N, Liso A, Macleod RA et al. Cell line OCI/AML3 bears exon-12 NPM gene mutation-A and cytoplasmic expression of nucleophosmin. Leukemia 2005; 19: 1760-1767. (Pubitemid 41486153)
15. Grisendi S, Mecucci C, Falini B, Pandolfi PP. Nucleophosmin and cancer. Nat Rev Cancer 2006; 6: 493-505. (Pubitemid 43980539)
16. Swaminathan V, Kishore AH, Febitha KK, Kundu TK. Human histone chaperone nucleophosmin enhances acetylation-dependent chromatin transcription. Mol Cell Biol 2005; 25: 7534-7545. (Pubitemid 41170116)
17. Wermke M, Thiede C, Kiani A, Ehninger G, Bornhauser M, Platzbecker U. Successful treatment of molecular relapse in NPM1-positive AML using 5-azacytidine. Leukemia 2010; 24: 236-237.